These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36609725)

  • 21. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant
    Katip W; Uitrakul S; Oberdorfer P
    Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 32998187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii.
    Jang JY; Kwon HY; Choi EH; Lee WY; Shim H; Bae KS
    J Crit Care; 2017 Aug; 40():251-256. PubMed ID: 28458172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients].
    Pérez-Pedrero MJ; Sánchez-Casado M; Rodríguez-Villar S
    Med Intensiva; 2011 May; 35(4):226-31. PubMed ID: 21396739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.
    Abdellatif S; Trifi A; Daly F; Mahjoub K; Nasri R; Ben Lakhal S
    Ann Intensive Care; 2016 Dec; 6(1):26. PubMed ID: 27033711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
    Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
    Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population.
    Bharathi KS; Bhat A; Pruthi G; Simha PP
    Ann Card Anaesth; 2022; 25(4):435-440. PubMed ID: 36254907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience.
    Shi R; Fu Y; Gan Y; Wu D; Zhou S; Huang M
    Front Pharmacol; 2023; 14():1222044. PubMed ID: 37719858
    [No Abstract]   [Full Text] [Related]  

  • 32. Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia.
    Boisson M; Bouglé A; Sole-Lleonart C; Dhanani J; Arvaniti K; Rello J; Rouby JJ; Mimoz O;
    Semin Respir Crit Care Med; 2022 Apr; 43(2):255-270. PubMed ID: 35042259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Vietnam: Antibiotic Resistance, Treatment Outcomes, and Colistin-Associated Adverse Effects.
    Vo TPM; Dinh TC; Phan HV; Cao TTM; Duong PT; Nguyen T
    Healthcare (Basel); 2022 Sep; 10(9):. PubMed ID: 36141377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria.
    Petrosillo N; Giannella M; Antonelli M; Antonini M; Barsic B; Belancic L; Inkaya A C; De Pascale G; Grilli E; Tumbarello M; Akova M
    Antimicrob Agents Chemother; 2014; 58(2):851-8. PubMed ID: 24277037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.
    Gu WJ; Wang F; Tang L; Bakker J; Liu JC
    Int J Antimicrob Agents; 2014 Dec; 44(6):477-85. PubMed ID: 25199968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.
    Zak-Doron Y; Dishon Benattar Y; Pfeffer I; Daikos GL; Skiada A; Antoniadou A; Durante-Mangoni E; Andini R; Cavezza G; Leibovici L; Yahav D; Eliakim-Raz N; Carmeli Y; Nutman A; Paul M;
    Clin Infect Dis; 2018 Nov; 67(12):1815-1823. PubMed ID: 29718143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study.
    Benattar YD; Omar M; Zusman O; Yahav D; Zak-Doron Y; Altunin S; Elbaz M; Daitch V; Granot M; Leibovici L; Paul M
    Clin Infect Dis; 2016 Dec; 63(12):1605-1612. PubMed ID: 27794023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
    Benítez-Cano A; de Antonio-Cuscó M; Luque S; Sorlí L; Carazo J; Ramos I; Bermejo S; Campillo N; Horcajada JP; Samsó E; Grau S
    J Antimicrob Chemother; 2019 Nov; 74(11):3268-3273. PubMed ID: 31495877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Mubareka S; Rubinstein E
    Crit Care; 2005 Feb; 9(1):29-30. PubMed ID: 15693979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.